Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic Abnormalities

This study has been completed.
Sponsor:
Collaborator:
Canadian Foundation for AIDS Research (CANFAR)
Information provided by (Responsible Party):
Johane Allard, University Health Network, Toronto
ClinicalTrials.gov Identifier:
NCT00152893
First received: September 8, 2005
Last updated: July 17, 2013
Last verified: July 2013